Interview highlights
0:05 – Role of the ESHLSG
1:31 – Why it was necessary to produce new guidance
2:50 – How Simon would like to see the guidance used in practice
3:49 – How Simon sees the relationship between the pharmaceutical industry and the NHS evolving over the next three to five years